Quick Answer
Drugs Made In America Acquisition Corp. reported Stockholders Equity of -$244.8 thousand for fiscal year 2024.
Drugs Made In America Acquisition Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$244.8K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.33M | -4345.3% | -2.5% |
| June 30, 2025 | -$7.15M | -35782.4% | +0.3% |
| March 31, 2025 | -$7.18M | — | -2831.0% |
| December 31, 2024 | -$244.8K | — | -48.5% |
| September 30, 2024 | -$164.9K | — | -727.1% |
| June 30, 2024 | -$19.9K | — | — |
- The most recent figure is from Drugs Made In America Acquisition Corp.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: